APhA CEO Michael Hogue urges Congress to pass the ECAPS Act to prevent the collapse of community health access — warning that continued inaction will leave vulnerable patients without essential pharmacy care.

In this blog, APhA CEO Michael Hogue reflects on the evolving nature of science and APhA’s role in championing evidence-based practice.

APhA CEO Michael Hogue makes the case for why direct-to-consumer drug programs must include pharmacists’ care — and why leaving them out would be a costly mistake.

In this blog, APhA CEO Michael Hogue shares how the Association is doubling down on its commitment to pharmacy workforce well-being and workplace conditions. He highlights investments in staff expertise, new partnerships like HealthShifts to tackle staffing challenges, advocacy for patient safety and sustainable reimbursement, and real solutions to support pharmacists on the frontlines.